Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2018-08-31

FDA Approved: ABSORICA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ABSORICA (isotretinoin) submitted by Sun Pharmaceutical Industries, resulting in an update to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ABSORICA (isotretinoin)

Snippet

SUPPL AP for ABSORICA (ISOTRETINOIN)